AMICUS THERAPEUTICS, INC. Deferred Tax Assets, Gross
AMICUS THERAPEUTICS, INC. had Deferred Tax Assets, Gross of $629.20 million as of 2025-12-31, per its 10-K filed 2026-02-20.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsGross · last filed 2026-02-20
- 2025-12-31: Deferred Tax Assets, Gross $629.20M.
- 2024-12-31: Deferred Tax Assets, Gross $617.17M.
- 2023-12-31: Deferred Tax Assets, Gross $659.26M.
- 2022-12-31: Deferred Tax Assets, Gross $707.61M.
| Period end | Deferred Tax Assets, Gross | Deferred Tax Assets, Gross as first filed |
|---|---|---|
| 2025-12-31 | $629.20M 10-K · filed 2026-02-20 | |
| 2024-12-31 | $617.17M 10-K · filed 2026-02-20 | |
| 2023-12-31 | $659.26M 10-K · filed 2025-02-19 | |
| 2022-12-31 | $707.61M 10-K · filed 2024-02-28 | |
| 2021-12-31 | $692.23M 10-K · filed 2023-03-01 | |
| 2020-12-31 | $602.43M 10-K · filed 2022-02-24 | |
| 2019-12-31 | $521.78M 10-K · filed 2021-03-01 | $516.87M 10-K · filed 2020-03-02 |
| 2018-12-31 | $430.11M 10-K · filed 2020-03-02 | |
| 2017-12-31 | $337.19M 10-K · filed 2019-02-28 | |
| 2016-12-31 | $383.63M 10-K · filed 2018-03-01 | $413.54M 10-K · filed 2017-03-01 |
| 2015-12-31 | $213.73M 10-K/A · filed 2017-03-03 | |
| 2014-12-31 | $148.44M 10-K · filed 2016-02-29 | |
| 2013-12-31 | $121.58M 10-K · filed 2015-03-03 | |
| 2012-12-31 | $95.33M 10-K · filed 2014-03-03 | |
| 2011-12-31 | $75.20M 10-K · filed 2013-03-13 |